TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vistin Pharma ASA
Closing information (x1000 EUR)
Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Turnover | 23,130 | 19,992 | 18,888 |
Financial expenses | 483 | 8,532 | 688 |
Earnings before taxes | 8,521 | -8,505 | 748 |
Total assets | 51,118 | 49,858 | 23,551 |
Current assets | 40,012 | 38,814 | 16,060 |
Current liabilities | 7,426 | 13,393 | 9,843 |
Equity capital | 41,915 | 34,782 | 12,211 |
- share capital | 4,496 | 4,421 | 1,733 |
Employees (average) | 0 | 65 | |
Shareholders | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Solvency | 82.0% | 69.8% | 51.8% |
Turnover per employee | 291 | ||
Profit as a percentage of turnover | 36.8% | -42.5% | 4.0% |
Return on assets (ROA) | 17.6% | 0.1% | 6.1% |
Current ratio | 538.8% | 289.8% | 163.2% |
Return on equity (ROE) | 20.3% | -24.5% | 6.1% |
Change turnover | 2,800 | 1,461 | -21,230 |
Change turnover % | 14% | 8% | -53% |
Chg. No. of employees | -65 | 65 | |
Chg. No. of employees % | -100% |
Total value of public sale
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.